PKI News and Press, PerkinElmer Inc. From 05/05/20

Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties PerkinElmer, Inc. (NYSE: PKI), a global leader c...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology ...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual BofA Securities Virtual Healthcare Conference 2020 on Thursday, May 14, 2020 at 8:20 a.m. ET. Prahlad Singh, president and chief exec...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, gave notice today that in response to continued public health restrictions on in-person gatherings given the coronavirus/COVID-19 pandemic, the Board of Directors of PerkinElmer has determined to c...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Tuesday, May 5, 2020, after market close, the Company will release first quarter 2020 results. The Company will also host a conference call the same day at 5:00 p.m. ET to d...

Beaumont Health's Research Institute has initiated a study, calling it the largest to date in the U.S., aimed at determining the prevalence of COVID-19 antibodies in its 38K employees and thousands of affiliates who have never reported any symptoms. More news on: PerkinElmer, Inc., Healt...

SOUTHFIELD, Mich. , April 13, 2020 /PRNewswire/ -- Beaumont Health's Research Institute is launching America's largest serological testing study to help answer many questions surrounding the spread of COVID-19 and potentially help treat patients battling the virus. Serologic...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test . Clinical laboratories certifi...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it expects first quarter 2020 revenue and earnings per share, both on a GAAP and non-GAAP basis, to be below the Company’s previously communicated guidance. Prahlad ...

Pfizer Misses Q4 Target, offers Soft Guidance Pfizer ( PFE ) stock stumbled as the company reported lower than expected numbers for its fourth quarter. It also provided lackluster guidance for the upcoming FY 2020. The company’s revenue fell as it lost exclusivity on its key drugs...